Task B2: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses

NIH RePORTER · NIH · N01 · $73,572 · view on reporter.nih.gov ↗

Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

Key facts

NIH application ID: 10116213
Project number: 75N93019D00021-P00001-759301900132-1
Recipient: UTAH STATE UNIVERSITY
Principal Investigator: CRAIG DAY
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $73,572
Award type: —
Project period: 2019-09-13 → 2020-09-12